{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:48:35Z","timestamp":1791330515425,"version":"4.3.1"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T00:00:00Z","timestamp":1392076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"National Institutes of Health, National Institute of NEurological Disorders and Stroke","award":["R37-NS31146"],"award-info":[{"award-number":["R37-NS31146"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2014,4]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Examine the possible association between long\u2010term seizure outcome in childhood absence epilepsy (\n                      <jats:styled-content style=\"fixed-case\">CAE<\/jats:styled-content>\n                      ) and the initial treatment choice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Children with\n                      <jats:styled-content style=\"fixed-case\">CAE<\/jats:styled-content>\n                      were prospectively recruited at initial diagnosis and followed in a community\u2010based cohort study. Children presenting with convulsive seizures, significant imaging abnormalities, or who were followed &lt;5\u00a0years were excluded. Early outcomes included success of initial medication, early remission, and pharmacoresistance. The primary long\u2010term outcome was complete remission: \u22655\u00a0years both seizure free and medication free. Survival methods were used for analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The first medication was ethosuximde (\n                      <jats:styled-content style=\"fixed-case\">ESM<\/jats:styled-content>\n                      ) in 41 (69%) and valproic acid (\n                      <jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content>\n                      ) in 18 (31%). Initial success rates were 59% (\n                      <jats:styled-content style=\"fixed-case\">ESM<\/jats:styled-content>\n                      ) and 56% (\n                      <jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content>\n                      ). Early remission and pharmacoresistance were similar in each group. Apart from atypical electroencephalography (EEG) features (61% [\n                      <jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content>\n                      ], 17% [\n                      <jats:styled-content style=\"fixed-case\">ESM<\/jats:styled-content>\n                      ]), no clinical features varied substantially between the treatment groups. Complete remission occurred in 31 children (76%) treated with\n                      <jats:styled-content style=\"fixed-case\">ESM<\/jats:styled-content>\n                      and 7 (39%) who received\n                      <jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content>\n                      (p\u00a0=\u00a00.007). Children with versus without atypical\n                      <jats:styled-content style=\"fixed-case\">EEG<\/jats:styled-content>\n                      features were less likely to enter complete remission (50% vs. 71%, p\u00a0=\u00a00.03). In a Cox regression,\n                      <jats:styled-content style=\"fixed-case\">ESM<\/jats:styled-content>\n                      was associated with a higher rate of complete remission than\n                      <jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content>\n                      (hazards ratio [\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      ]\u00a02.5, 95% confidence interval [CI] 1.1\u20136.0; p\u00a0=\u00a00.03). Atypical\n                      <jats:styled-content style=\"fixed-case\">EEG<\/jats:styled-content>\n                      features did not independently predict outcome (p\u00a0=\u00a00.15). Five\u2010year and 10\u2010year remission, regardless of continued treatment, occurred more often in children initially treated with\n                      <jats:styled-content style=\"fixed-case\">ESM<\/jats:styled-content>\n                      versus\n                      <jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance<\/jats:title>\n                    <jats:p>\n                      These findings are congruent with results of studies in genetic absence models in rats and provide preliminary evidence motivating a hypothesis regarding potential disease\u2010modifying effects of\n                      <jats:styled-content style=\"fixed-case\">ESM<\/jats:styled-content>\n                      in CAE.\n                    <\/jats:p>\n                    <jats:p>\n                      A PowerPoint slide summarizing this article is available for download in the Supporting Information section\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/epi.12551\/suppinfo\">here<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/epi.12551","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T05:36:37Z","timestamp":1392183397000},"page":"551-557","source":"Crossref","is-referenced-by-count":70,"title":["Long\u2010term seizure remission in childhood absence epilepsy: Might initial treatment matter?"],"prefix":"10.1111","volume":"55","author":[{"given":"Anne T.","family":"Berg","sequence":"first","affiliation":[{"name":"Department of Pediatrics Epilepsy Center Ann &amp; Robert H. Lurie Children's Hospital of Chicago Chicago Illinois U.S.A"},{"name":"the Northwestern Memorial Feinberg School of Medicine Chicago Illinois U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Neurology Yale School of Medicine New Haven Connecticut U.S.A"},{"name":"Department of Pediatrics Yale School of Medicine New Haven Connecticut U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine M.","family":"Testa","sequence":"additional","affiliation":[{"name":"Department of Neurology Yale School of Medicine New Haven Connecticut U.S.A"},{"name":"Department of Pediatrics Yale School of Medicine New Haven Connecticut U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hal","family":"Blumenfeld","sequence":"additional","affiliation":[{"name":"Department of Neurology Yale School of Medicine New Haven Connecticut U.S.A"},{"name":"Department of Neurobiology Yale School of Medicine New Haven Connecticut U.S.A"},{"name":"Department of Neurosurgery Yale School of Medicine New Haven Connecticut U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,2,11]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp187"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01382.x"},{"key":"e_1_2_7_4_1","first-page":"113","volume-title":"Prognosis of epilepsies","author":"Camfield P","year":"2003"},{"key":"e_1_2_7_5_1","volume-title":"Epileptic syndromes in infancy, childhood, and adolescence","author":"Roger J","year":"1992"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.3.802"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410130610"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12074"},{"key":"e_1_2_7_9_1","first-page":"656","article-title":"Management of childhood epilepsy","volume":"19","author":"Glauser TA","year":"2013","journal-title":"CONTINUUM"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12028"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902014"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01458.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12118"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000228257.60184.82"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01461.x"},{"key":"e_1_2_7_16_1","first-page":"285","volume-title":"Epileptic syndromes in infancy, childhood and adolescence","author":"Loiseau P","year":"2002"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/112.4.1039"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.00277.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4471-1401-7_6"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02397.x"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(79)90012-2"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0887-8994(91)90004-5"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01708.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.02001.x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2011.03.036"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03119.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1997.02170390042008"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02260.x"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22672"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422507"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fepi.12551","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/epi.12551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T18:48:09Z","timestamp":1696272489000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/epi.12551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,11]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.1111\/epi.12551"],"URL":"https:\/\/doi.org\/10.1111\/epi.12551","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,11]]}}}